| abstract |
Compound N- [2- (2, 1, 3-benzothiadiazol-5-ylamino) -6- (2, 6-dichlorophenyl) pyrido [2,3-d] pyrimidin-7-yl] -N'- (1, 1-dimethylethyl) urea or a hydrate, a salt or solvate thereof, for use in the treatment of myeloid leukemias, for intra-peritoneal administration, intravenously followed by intraperitoneal administration or via intravenously followed by oral administration. |